跳至主要内容
临床试验/NCT06039111
NCT06039111
招募中
2 期

Indocyanine Green for Detection of Sentinel Lymph Nodes In Comparison to ICG Plus Technetium in the Evaluation of Vulvar Squamous Cell Carcinoma: The IGNITE-V Study

Hamilton Health Sciences Corporation1 个研究点 分布在 1 个国家目标入组 58 人2023年10月1日
适应症Vulvar Cancer
干预措施ICG alone

概览

阶段
2 期
干预措施
ICG alone
疾病 / 适应症
Vulvar Cancer
发起方
Hamilton Health Sciences Corporation
入组人数
58
试验地点
1
主要终点
false-negative rate of the detection technique using ICG alone compared to ICG and Technetium (Dual method) per groin
状态
招募中
最后更新
19天前

概览

简要总结

The aim of this study is to confirm prospectively if the use of near infrared-indocyanine green (NIR-ICG) alone offers similar accuracy and sensitivity to the gold standard dual technique for sentinel lymph node detection in early stage vulvar cancer.

注册库
clinicaltrials.gov
开始日期
2023年10月1日
结束日期
2026年11月30日
最后更新
19天前
研究类型
Observational
研究设计
Single Group
性别
Female

研究者

责任方
Principal Investigator
主要研究者

Andra Nica

Gynecologic Oncologist

Hamilton Health Sciences Corporation

入排标准

入选标准

  • Adult women (18 years of age) with FIGO Stage IB (\> 1 mm depth of invasion) and small Stage II (4 cm) vulvar squamous cell carcinoma or cutaneous melanoma who are candidates for the Sentinel lymph node technique will be included (Negative clinical groin examination and/or imaging and primary unifocal vulvar tumor size of \< 4 cm).

排除标准

  • Women with a prior history of pelvic, vulvovaginal or inguinal radiation, with allergy or hypersensitivity to Technetium or ICG, or Bartholin gland cancer will be excluded.

研究组 & 干预措施

Sequential ICG and Technetium Detection

ICG alone for the detection of SLN in early vulvar cancer

干预措施: ICG alone

结局指标

主要结局

false-negative rate of the detection technique using ICG alone compared to ICG and Technetium (Dual method) per groin

时间窗: 2 years

This will be calculated as the number of groins for which positive SLN were missed using ICG alone; i.e. the number of groins for which ICG did not detect a positive SLN but was detected by ICG and Technetium, divided by the number of groins for which surgery was performed.

次要结局

  • 1. The proportion of positive SLN detected by ICG for each groin divided by the total number of positive SLN detected using ICG and Technetium.(2 years)

研究点 (1)

Loading locations...

相似试验